NCT06965699

Brief Summary

The goal of this clinical trial is to determine whether meals fortified with plant-based high protein sauce (ProSauce) provide better metabolic availability of essential amino acids compared to meals with standard lower-protein sauce without resulting in excessive gut fullness and satiety. The main questions it aims to answer are: Does meals with high-protein sauce deliver better metabolic availability of amino acid profile? Does this high-protein sauce also not lead to excessive appetite suppression due to its liquid form? Researchers will compare high protein sauce to a commercially available standard low protein sauce. Participants will consume two meals, either protein-fortified or standard low-protein sauce, in a randomised order with at least a one-week washout period between each meal. The investigators will collect venous blood samples over a 6-hour postprandial period to measure plasma essential (and non-essential) amino acid and insulin concentrations. The investigators will also measure appetite-related hormones from venous plasma and assess subjective appetite using a visual analogue scale, taken in parallel with the blood sample time points.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 23, 2025

Completed
18 days until next milestone

First Posted

Study publicly available on registry

May 11, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

July 10, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2026

Completed
Last Updated

September 23, 2025

Status Verified

September 1, 2025

Enrollment Period

4 months

First QC Date

April 23, 2025

Last Update Submit

September 17, 2025

Conditions

Keywords

plant-based protein sauceolder adultsamino acid metabolic availabilityappetite regulation

Outcome Measures

Primary Outcomes (1)

  • Concentrations of essential amino acids

    Baseline and postprandial plasma amino acid concentrations will be measured to provides valuable insights into protein digestion and absorption.

    Essential amino acid concentrations at time points of baseline, immediately after breakfast (t =0 minute) and t = 20, 40, 60, 90, 120, 180, 240, 300, 360 minutes.

Secondary Outcomes (1)

  • Concentrations of appetite-related gut hormones

    Appetite-related gut hormones will be measured at time points of baseline, immediately after breakfast (t =0 minute) and t = 20, 40, 60, 90, 120, 150, 180, 210, 240 minutes.

Study Arms (2)

ProSauce

EXPERIMENTAL
Dietary Supplement: ProSauce

standard sauce

PLACEBO COMPARATOR
Dietary Supplement: low-protein sauce

Interventions

ProSauceDIETARY_SUPPLEMENT

10g additional protein from ProSauce

ProSauce
low-protein sauceDIETARY_SUPPLEMENT

Commercially available standard low-protein sauce

standard sauce

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 60 and over
  • Living independently in the community
  • Capacity to provide informed consent
  • Non-smoking (vaping is considered smoking)
  • No known medical conditions that might influence the study outcomes, e.g., heart disease, diabetes mellitus, obesity, disthyroidism and other endocrinopathies and renal failure
  • Not taking any medications that might influence the study outcomes e.g., taking anabolic steroids or corticosteroids long term
  • No clinically diagnosed eating disorders
  • No severe dislike or allergy to any of the study food
  • No hospitalisations in the last 6 months
  • Not dieting and weight stable for 3 months before the study (\< 3 kg change in weight)

You may not qualify if:

  • Age \< 60y
  • Smoking
  • Food allergies
  • Cognitive and mobility issues
  • Hospitalisation in the last 6 months
  • Known medical conditions that might influence the study outcomes
  • Taking medications that influence the study outcomes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Exeter

Exeter, Devon, EX44DZ, United Kingdom

RECRUITING

MeSH Terms

Conditions

Kwashiorkor

Condition Hierarchy (Ancestors)

Severe Acute MalnutritionMalnutritionNutrition DisordersNutritional and Metabolic Diseases

Study Officials

  • Joanna Bowtell, Prof

    University of Exeter

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Zhuoxiu Jin, Dr

CONTACT

Joanna Bowtell, Prof

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 23, 2025

First Posted

May 11, 2025

Study Start

July 10, 2025

Primary Completion

October 30, 2025

Study Completion

April 30, 2026

Last Updated

September 23, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations